- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
May 4th, 2006
Jurilab, a privately-held Finnish biotechnology company, and Nanogen announce that the European CE Mark for IVD (in vitro diagnostic) use has been achieved for the Drugmet pharmacogenetic test.
Nanogen's ten years of pioneering research involving nanotechnology holds the promise of miniaturization and continues to be supported for its potential for diagnostic and biodefence applications.
|Related News Press|
Nanoparticles present sustainable way to grow food crops May 1st, 2016
Cooling graphene-based film close to pilot-scale production April 30th, 2016